NEW CASES

FULLY
EQUIPPED

Shareholders Class Action Filed Against Envision Healthcare Corporation

Notice is hereby given that a class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Envision Healthcare Corporation f/k/a Envision Healthcare Holdings, Inc. (“Envision”) (NYSE: EVHC) securities between March 2, 2015 and July 21, 2017, both dates inclusive (the “Class Period”).  
 

Envision investors may receive additional information about the case by clicking the link "Join this Class Action" above.

According to the complaint, Envision provides health care services, including surgery, pharmacy, medical imaging, emergency care, and other related health care services, to patients in the United States.

The Class Period commences on March 2, 2015, when Envision filed an Annual Report on Form 10-K with the SEC, reporting the company’s financial and operating results for the quarter and year ended December 31, 2014.

The complaint alleges that, on July 24, 2017, The New York Times reported that hospitals associated with Envision’s subsidiary EmCare Holdings Inc. (“EmCare”) were disproportionately likely to engage in “surprise billing,” in which patients who go to in-network hospitals are treated by out-of-network doctors and subsequently billed at higher rates.

Following this news, Envision’s share price fell $2.33, or 3.72%, to close at $60.28 on July 24, 2017.

The complaint alleges that, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (i) EmCare routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of- network physicians; (ii) EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians; (iii) the company’s statements attributing EmCare’s Class Period growth to other factors were therefore false and/or misleading; (iv) Envision’s EmCare revenues were likely to be unsustainable after the foregoing conduct came to light; and (v) as a result of the foregoing, Envision’s public statements were materially false and misleading at all relevant times.

If you are a member of the class described above, you may no later than October 3, 2017, move the Court to serve as lead plaintiff of the class, if you so choose.

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff.  Any member of the purported class may move the court to serve as a lead plaintiff through counsel of their choice, or may choose to do nothing and remain an inactive class member.

Kessler Topaz Meltzer & Check, LLP has not filed a complaint in this matter. If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at info@ktmc.com. For more information about Kessler Topaz Meltzer & Check, LLP, please visit our website at http://www.ktmc.com. If you would like additional information about the suit, please fill out the attached form as promptly as possible and return it by fax to 610-667-7056, or by mail in the enclosed envelope.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Esq. or
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
1-888-299-7706 (toll free) or 1-610-667-7706
Or by e-mail at info@ktmc.com
 

Please complete this form and list your purchase and sale transaction(s) for Envision Healthcare Corporation f/k/a Envision Healthcare Holdings, Inc. (“Envision”) (NYSE: EVHC) securities between March 2, 2015 and July 21, 2017, both dates inclusive (the “Class Period”):

Information Sheet
* Denotes required field
Acquisitions
Date Aquired
Number of Shares Acquired
Acquisition Price Per Share
Sales
Date Sold
Number of Shares Sold
Selling Price Per Share
Did you purchase shares of Envision Healthcare Corporation prior to the class period?
Are you a current or former employee of Envision Healthcare Corporation?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
How did you hear about this case?
Sign Up for Monthly Update: